Published November 20, 2019
| Version v1
Patent
Open
An Anti-Diabetic Formulation consisting AMPk &GlUT4 mRNA Expression Enhancing Features
Authors/Creators
Description
An Anti-Diabetic Formulation that exerts effects via upregulating Beta-Islet cell proliferation; enhancing GLUT4 Translocation; enhancing insulin release and AMPK mRNA Expresion.
Files
Files
(24.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:8117f869be66c63f1984dc58830f595d
|
24.0 kB | Download |